(Q41476761)
Statements
Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor (English)
Modjtahedi H
Eccles S
Sandle J
Box G
Titley J
1 April 1994